Cervical Cancer – China Cancer Help

FERTILITY PRESERVATION & PRECISION BRACHYTHERAPY

Advanced Cervical Cancer Care in China

Cervical cancer care in China combines fertility-sparing surgical innovations for young women with advanced 3D image-guided brachytherapy and targeted immunotherapy for locally advanced disease. Top gynecologic oncology institutes provide curative protocols designed to eradicate tumors while preserving ovarian function and quality of life.

ADVANCED TREATMENT OPTIONS

Key Cervical Cancer Treatments

Fertility-sparing radical trachelectomy, 3D MRI-guided internal brachytherapy, and dual-action immunotherapies.

Fertility-Sparing Trachelectomy

Careful surgical removal of the cervix and pelvic lymph nodes while preserving the uterine body and ovaries, allowing women to carry future pregnancies.

Learn More

3D MRI-Guided Brachytherapy

High-dose internal radiation placed right at the tumor site under MRI guidance, delivering maximum cancer-killing dose while sparing the bladder and bowel.

Learn More

Dual Immunotherapy & Biologics

Evidence-based combinations of anti-PD-1 antibodies with anti-angiogenic agents and novel antibody-drug conjugates (ADCs) for refractory disease.

Learn More

WHY CHOOSE US

Why Choose China for Cervical Cancer

A patient-first clinical pathway connecting international women directly with premier gynecologic oncology institutes in China.

China operates some of the world’s most experienced gynecologic oncology hospitals. Centers of excellence excel in fertility-sparing radical trachelectomies, allowing hundreds of young women with early cervical cancer to safely preserve their reproductive potential and successfully deliver healthy babies.

For locally advanced cases, advanced 3D image-guided brachytherapy paired with concurrent chemoradiotherapy and immunotherapy achieves high cure rates with low bowel and urinary toxicity. Patients receive compassionate bilingual support and transparent public hospital pricing.

HOW IT WORKS

4 Steps to Treatment in China

A simple, step-by-step process from initial record review to your arrival and treatment in China.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international patients considering care in China.

01. Can young women with cervical cancer preserve their ability to have children?

Yes. Radical trachelectomy removes the cervix and surrounding tissue while leaving the uterus and ovaries intact, making future pregnancy achievable for eligible early-stage patients.

02. How does 3D MRI-guided brachytherapy protect healthy organs?

Internal radiation applicators are scanned with real-time 3D MRI, allowing radiation physicists to tailor the radiation cloud tightly around the tumor and keep high doses away from the bladder and rectum.

03. What treatments are available for recurrent cervical cancer?

Patients can access approved PD-1 checkpoint inhibitors combined with targeted anti-angiogenic drugs and next-generation antibody-drug conjugates.

04. How are international cases evaluated before travel?

Your pelvic MRI scans, pathology slides, HPV status, and clinical notes are reviewed by senior gynecologic oncologists within 48 hours.

CONFIDENTIAL CASE EVALUATION

Start with a Confidential Clinical Case Review

Submit your basic case details below for an initial eligibility review. Our medical team coordinates directly with chief oncologists at top Chinese cancer centers, returning a preliminary assessment and roadmap within 24–48 hours.

✓ Free initial triage • ✓ Direct specialist coordination • ✓ 100% Confidential